| 0 |
Surfactant [EPC] |
3 |
0.0026 |
| 1 |
Paramagnetic Contrast Agent [EPC] |
5 |
0.0011 |
| 2 |
Endoglycosidase [EPC] |
1 |
0.0005 |
| 3 |
Aryl Hydrocarbon Receptor Agonist [EPC] |
1 |
0.0005 |
| 4 |
Interleukin-17 Receptor A Antagonist [EPC] |
1 |
0.0005 |
| 5 |
alpha-Glucosidase Inhibitor [EPC] |
1 |
0.0002 |
| 6 |
Echinocandin Antifungal [EPC] |
1 |
0.0001 |
| 7 |
Substance P/Neurokinin-1 Receptor Antagonist [EPC] |
1 |
0.0001 |
| 8 |
Antifibrinolytic Agent [EPC] |
1 |
0.0001 |
| 9 |
CD30-directed Immunoconjugate [EPC] |
1 |
0.0001 |
| 10 |
Antisense Oligonucleotide [EPC] |
1 |
0.0001 |
| 11 |
Microtubule Inhibitor [EPC] |
13 |
0.0001 |
| 12 |
Lipid-based Polyene Antifungal [EPC] |
1 |
0.0001 |
| 13 |
Prostacyclin Receptor Agonist [EPC] |
2 |
0.0001 |
| 14 |
GLP-2 Analog [EPC] |
1 |
0.0001 |
| 15 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
7 |
0.0001 |
| 16 |
Human Immunoglobulin G [EPC] |
1 |
0.0000 |
| 17 |
Bile Acid [EPC] |
1 |
0.0000 |
| 18 |
HER2/neu Receptor Antagonist [EPC] |
3 |
0.0000 |
| 19 |
PCSK9 Inhibitor [EPC] |
1 |
0.0000 |
| 20 |
Prostaglandin Analog [EPC] |
3 |
0.0000 |
| 21 |
Aldosterone Antagonist [EPC] |
4 |
0.0000 |
| 22 |
Polyene Antifungal [EPC] |
1 |
0.0000 |
| 23 |
Aminoglycoside Antibacterial [EPC] |
1 |
0.0000 |
| 24 |
Phosphodiesterase 5 Inhibitor [EPC] |
3 |
0.0000 |
| 25 |
Platinum-based Drug [EPC] |
6 |
0.0000 |
| 26 |
Interleukin-6 Receptor Antagonist [EPC] |
3 |
0.0000 |
| 27 |
Insulin [EPC] |
1 |
0.0000 |
| 28 |
Endothelin Receptor Antagonist [EPC] |
4 |
0.0000 |
| 29 |
Complement Inhibitor [EPC] |
1 |
0.0000 |
| 30 |
Alkylating Drug [EPC] |
4 |
0.0000 |
| 31 |
Antidote [EPC] |
1 |
0.0000 |
| 32 |
Cardiac Glycoside [EPC] |
1 |
0.0000 |
| 33 |
Loop Diuretic [EPC] |
6 |
0.0000 |
| 34 |
Xanthine Oxidase Inhibitor [EPC] |
2 |
0.0000 |
| 35 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
1 |
0.0000 |
| 36 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
2 |
0.0000 |
| 37 |
Purine Antimetabolite [EPC] |
1 |
0.0000 |
| 38 |
Aminosalicylate [EPC] |
1 |
0.0000 |
| 39 |
Mood Stabilizer [EPC] |
2 |
0.0000 |
| 40 |
Aromatase Inhibitor [EPC] |
1 |
0.0000 |
| 41 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
1 |
0.0000 |
| 42 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
1 |
0.0000 |
| 43 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
1 |
0.0000 |
| 44 |
Kinase Inhibitor [EPC] |
4 |
0.0000 |
| 45 |
alpha-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 46 |
Corticosteroid [EPC] |
9 |
0.0000 |
| 47 |
beta-Adrenergic Blocker [EPC] |
2 |
0.0000 |
| 48 |
Azole Antifungal [EPC] |
1 |
0.0000 |
| 49 |
Interferon beta [EPC] |
1 |
0.0000 |
| 50 |
Folate Analog Metabolic Inhibitor [EPC] |
2 |
0.0000 |
| 51 |
Anti-epileptic Agent [EPC] |
1 |
0.0000 |
| 52 |
Retinoid [EPC] |
1 |
0.0000 |
| 53 |
Platelet Aggregation Inhibitor [EPC] |
2 |
0.0000 |
| 54 |
Proton Pump Inhibitor [EPC] |
2 |
0.0000 |
| 55 |
CD20-directed Cytolytic Antibody [EPC] |
1 |
0.0000 |
| 56 |
Angiotensin 2 Receptor Blocker [EPC] |
1 |
0.0000 |
| 57 |
Dihydropyridine Calcium Channel Blocker [EPC] |
1 |
0.0000 |
| 58 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
3 |
0.0000 |
| 59 |
GLP-1 Receptor Agonist [EPC] |
1 |
0.0000 |
| 60 |
Insulin Analog [EPC] |
1 |
0.0000 |
| 61 |
Atypical Antipsychotic [EPC] |
1 |
0.0000 |
| 62 |
Tumor Necrosis Factor Blocker [EPC] |
2 |
0.0000 |
| 63 |
Benzodiazepine [EPC] |
1 |
0.0000 |